Orange Book product · Generic (ANDA)
TRAVOPROST
TRAVOPROST
At a glance
Mar 01, 2013
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 01, 2013
13 yr 6 mo ago
Today
Pharmaceutical detail
Active ingredient
TRAVOPROST
Strength
0.004%
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
TE code
Not listed
Application
ANDA 091340
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
Yes
Active-ingredient family
View full familyGeneric (ANDA) of TRAVOPROST
- 2023IDOSE TRBrand (NDA)
NDA 218010 · GLAUKOS
- 2014IZBABrand (NDA)
NDA 204822 · NOVARTIS
- 2006TRAVATAN ZBrand (NDA)
NDA 021994 · SANDOZ
- 2001TRAVATANBrand (NDA)
NDA 021257 · ALCON PHARMS LTD
- 2025TRAVOPROSTGeneric (ANDA)
ANDA 214687 · ALEMBIC
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 217228 · SOMERSET THERAPS LLC
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 218159 · GLAND
- 2024TRAVOPROSTGeneric (ANDA)
ANDA 207040 · LUPIN
- 2021TRAVOPROSTGeneric (ANDA)
ANDA 203767 · MICRO LABS
- 2019TRAVOPROSTGeneric (ANDA)
ANDA 210458 · ALEMBIC
- 2017TRAVOPROSTGeneric (ANDA)
ANDA 205050 · MYLAN
- 2015TRAVOPROSTGeneric (ANDA)
ANDA 203431 · APOTEX
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
